OxyContin maker's settlement plan divides victims of opioid crisis. Now it's up to the Supreme Court

Settlement Plan by Purdue Pharma: Purdue Pharma has agreed to settle thousands of lawsuits related to the opioid crisis, which involves giving up company ownership and contributing up to $6 billion.

Sackler Family Immunity: As part of the settlement, the Sackler family, who profited significantly from OxyContin sales, would be granted immunity from future civil lawsuits.

Supreme Court Involvement: The legality of this settlement agreement, particularly the aspect of granting immunity to the Sacklers, is set to be reviewed by the Supreme Court.

Divided Reactions Among Victims: The settlement has led to a split in opinion among victims of the opioid crisis, with some supporting it for the potential benefits and others opposing it due to moral and ethical concerns.

Broader Legal and Ethical Implications: The case raises important questions about the use of bankruptcy for resolving major product liability lawsuits and the moral implications of such settlements, especially in cases involving public health crises like the opioid epidemic.